Interpace Biosciences, Inc. (IDXG)
1.82
-0.03
(-1.62%)
USD |
OTCM |
Feb 10, 16:00
Interpace Biosciences Market Cap : 8.060M for Feb. 10, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| FONAR Corp. | 117.80M |
| Thermo Fisher Scientific, Inc. | 202.81B |
| XWELL, Inc. | 2.067M |
| Hypha Labs, Inc. | 5.132M |
| Veracyte, Inc. | 2.927B |
Market Cap Related Metrics
| PE Ratio | 6.766 |
| PS Ratio | 0.6973 |
| Price to Free Cash Flow | 6.597 |
| Price | 1.82 |
| Earnings Yield | 14.78% |
| Operating PE Ratio | 6.399 |
| Normalized PE Ratio | 6.468 |